Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Analysis of Short-term (Operating) Activity Ratios 

Microsoft Excel

Short-term Activity Ratios (Summary)

Medtronic PLC, short-term (operating) activity ratios

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Turnover Ratios
Inventory turnover 2.14 2.12 2.15 2.03 2.20 2.43
Receivables turnover 5.47 5.15 5.28 5.21 5.71 5.51
Payables turnover 4.81 4.75 4.65 4.03 4.46 4.98
Working capital turnover 2.77 3.07 2.90 2.47 2.97 2.15
Average No. Days
Average inventory processing period 171 172 170 180 166 150
Add: Average receivable collection period 67 71 69 70 64 66
Operating cycle 238 243 239 250 230 216
Less: Average payables payment period 76 77 78 91 82 73
Cash conversion cycle 162 166 161 159 148 143

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The operational activity ratios indicate a general trend of decelerating efficiency in the conversion of resources into cash over the observed period. While several metrics show stabilization in the later years, the overall cash conversion cycle has lengthened, reflecting a slower recovery of working capital.

Inventory Management
A decline in inventory turnover is observed from 2.43 in 2021 to a low of 2.03 in 2023, before stabilizing between 2.12 and 2.15 in the subsequent years. This corresponds with an increase in the average inventory processing period, which rose from 150 days to a peak of 180 days in 2023, eventually settling around 171 days. This pattern suggests a reduction in inventory throughput efficiency compared to the initial period.
Receivables and Collections
The receivables turnover and the average receivable collection period remain relatively stable. The turnover ratio fluctuated within a narrow range of 5.15 to 5.71, while the collection period stayed between 64 and 71 days. This stability indicates consistent credit management and a steady pace of collections from customers.
Payables and Obligations
Payables turnover exhibited a dip to 4.03 in 2023, coinciding with a peak in the average payables payment period of 91 days. In the latter years, the turnover recovered to 4.81 by 2026, with the payment period compressing to 76 days. This suggests a period of extended payment terms in 2023 followed by a return to more normalized payment cycles.
Working Capital and Operating Cycles
Working capital turnover increased from 2.15 in 2021 to a peak of 3.07 in 2025, indicating a more aggressive use of working capital to support revenue. However, the operating cycle lengthened from 216 days in 2021 to 238 days in 2026. Most notably, the cash conversion cycle shows a consistent upward trajectory, moving from 143 days in 2021 to 162 days in 2026, signaling that more capital is tied up in operations for longer durations.

AI Ask an analyst for more


Turnover Ratios


Average No. Days


Inventory Turnover

Medtronic PLC, inventory turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets 12,721 11,632 11,216 10,719 10,145 10,483
Inventories 5,951 5,476 5,217 5,293 4,616 4,313
Short-term Activity Ratio
Inventory turnover1 2.14 2.12 2.15 2.03 2.20 2.43
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 2.98 3.02 2.74 3.10 3.59
Intuitive Surgical Inc. 1.86 1.83 1.96 2.27 2.98
Inventory Turnover, Sector
Health Care Equipment & Services 35.97 32.90 30.37 30.70 31.85
Inventory Turnover, Industry
Health Care 7.55 7.56 7.36 7.85 7.90

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Inventory turnover = Cost of products sold, excluding amortization of intangible assets ÷ Inventories
= 12,721 ÷ 5,951 = 2.14

2 Click competitor name to see calculations.


An analysis of the short-term operating activity indicates a period of adjustment in inventory management, characterized by an initial decline in turnover efficiency followed by a phase of stabilization. While both costs of products sold and total inventory levels increased over the observed period, the rate of inventory accumulation initially exceeded the growth in product costs, impacting the overall turnover velocity.

Cost of Products Sold Trends
The cost of products sold, excluding amortization of intangible assets, demonstrates a consistent upward trajectory from 2022 onward. After a slight contraction between April 2021 and April 2022, where values moved from 10,483 million to 10,145 million US$, the costs grew steadily each subsequent year, reaching 12,721 million US$ by April 2026. This growth suggests an expansion in operational scale or an increase in the cost of raw materials and manufacturing.
Inventory Level Evolution
Inventories experienced a significant increase over the six-year period, rising from 4,313 million US$ in 2021 to 5,951 million US$ in 2026. A notable peak occurred in April 2023 at 5,293 million US$, followed by a marginal reduction to 5,217 million US$ in 2024, before resuming an upward climb. The overall increase in inventory holdings indicates a strategic build-up of stock or a slower liquidation of assets relative to production.
Inventory Turnover Performance
The inventory turnover ratio exhibits a distinct two-phase pattern. From April 2021 to April 2023, the ratio declined from 2.43 to 2.03, reflecting a decrease in the efficiency of inventory utilization and a longer average holding period. However, from April 2024 through April 2026, the ratio stabilized within a narrow range between 2.12 and 2.15. This stabilization suggests that the organization has reached a new equilibrium where the growth in cost of products sold is aligned with the growth in inventory investment.

AI Ask an analyst for more


Receivables Turnover

Medtronic PLC, receivables turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Net sales 36,364 33,537 32,364 31,227 31,686 30,117
Accounts receivable, less allowances and credit losses 6,643 6,515 6,128 5,998 5,551 5,462
Short-term Activity Ratio
Receivables turnover1 5.47 5.15 5.28 5.21 5.71 5.51
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 5.59 6.06 6.11 7.02 6.64
Elevance Health Inc. 16.34 18.00 18.08 18.81 20.66
Intuitive Surgical Inc. 6.59 6.82 6.30 6.60 7.30
UnitedHealth Group Inc. 19.27 17.66 17.27 18.22 20.07
Receivables Turnover, Sector
Health Care Equipment & Services 14.19 13.93 13.74 14.33 14.76
Receivables Turnover, Industry
Health Care 7.58 7.97 7.66 8.22 8.00

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Receivables turnover = Net sales ÷ Accounts receivable, less allowances and credit losses
= 36,364 ÷ 6,643 = 5.47

2 Click competitor name to see calculations.


The relationship between net sales and accounts receivable indicates a period of general expansion, though the efficiency of credit collection has experienced notable volatility. While net sales demonstrate a long-term upward trajectory, the consistent growth in receivables has led to fluctuations in the turnover ratio, reflecting varying levels of liquidity management efficiency.

Net Sales Trajectory
Net sales grew from 30,117 million in 2021 to 36,364 million by 2026. Although a slight contraction was observed in 2023, the subsequent years show accelerating growth, particularly between 2025 and 2026.
Accounts Receivable Growth
A steady and uninterrupted increase in accounts receivable is observed, rising from 5,462 million in 2021 to 6,643 million in 2026. This consistent climb suggests a corresponding increase in the volume of outstanding credit extended to customers to support sales growth.
Receivables Turnover Performance
The turnover ratio peaked at 5.71 in 2022, indicating optimal collection efficiency. A subsequent decline occurred, reaching a low of 5.15 in 2025, which suggests a slowdown in the rate at which receivables were converted into cash. However, a recovery to 5.47 is evident in 2026, signaling an improvement in credit collection processes and operational efficiency toward the end of the analyzed period.

AI Ask an analyst for more


Payables Turnover

Medtronic PLC, payables turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets 12,721 11,632 11,216 10,719 10,145 10,483
Accounts payable 2,644 2,449 2,410 2,662 2,276 2,106
Short-term Activity Ratio
Payables turnover1 4.81 4.75 4.65 4.03 4.46 4.98
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories 4.56 4.46 4.19 4.15 4.21
Elevance Health Inc. 8.68 8.10 7.72 7.47 7.59
Intuitive Surgical Inc. 13.42 14.05 12.69 13.78 14.45
UnitedHealth Group Inc. 7.98 7.72 7.47 7.26 7.63
Payables Turnover, Sector
Health Care Equipment & Services 7.84 7.48 7.14 6.94 7.18
Payables Turnover, Industry
Health Care 6.15 6.10 5.97 5.79 5.84

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Payables turnover = Cost of products sold, excluding amortization of intangible assets ÷ Accounts payable
= 12,721 ÷ 2,644 = 4.81

2 Click competitor name to see calculations.


Analysis of short-term operating activity reveals a fluctuating trend in payables management between 2021 and 2026. While the cost of products sold shows a consistent upward trajectory after 2022, the efficiency of payment cycles underwent a period of deceleration followed by a steady recovery.

Payables Turnover Trend
The payables turnover ratio exhibited a downward trend from 4.98 in 2021 to a low of 4.03 in 2023. This decline indicates a slowing of the payment cycle, suggesting that obligations to suppliers were settled less frequently during this period. Starting in 2024, the ratio reversed trend, climbing steadily to 4.65, 4.75, and reaching 4.81 by 2026, which signifies an acceleration in the settlement of short-term liabilities.
Cost of Products Sold and Payables Correlation
The cost of products sold increased from US$ 10,483 million in 2021 to US$ 12,721 million by 2026, reflecting a general increase in operational scale. During the period of declining turnover from 2021 to 2023, accounts payable grew more rapidly than the cost of sales, peaking at US$ 2,662 million. In contrast, between 2024 and 2026, the recovery in the turnover ratio was driven by a more controlled growth in accounts payable relative to the rising costs of products sold.
Operational Implications
The transition from a ratio of 4.03 in 2023 to 4.81 in 2026 indicates a shift toward more frequent supplier payments. This pattern suggests a strategic movement toward reducing the average payment period or a response to tighter credit terms provided by vendors, effectively increasing the velocity of cash outflows related to inventory and production costs.

AI Ask an analyst for more


Working Capital Turnover

Medtronic PLC, working capital turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Current assets 24,787 23,814 21,935 21,675 23,059 22,548
Less: Current liabilities 11,658 12,879 10,789 9,051 12,394 8,509
Working capital 13,129 10,935 11,146 12,624 10,665 14,039
 
Net sales 36,364 33,537 32,364 31,227 31,686 30,117
Short-term Activity Ratio
Working capital turnover1 2.77 3.07 2.90 2.47 2.97 2.15
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 4.67 4.42 4.54 4.48 3.87
Elevance Health Inc. 7.50 7.85 7.83 8.37 7.23
Intuitive Surgical Inc. 1.29 1.56 1.14 1.29 1.22
UnitedHealth Group Inc.
Working Capital Turnover, Sector
Health Care Equipment & Services 26.92 23.57 23.27 25.59 16.28
Working Capital Turnover, Industry
Health Care 11.25 12.35 10.99 11.30 8.57

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Working capital turnover = Net sales ÷ Working capital
= 36,364 ÷ 13,129 = 2.77

2 Click competitor name to see calculations.


The analysis of operating activity reveals a general improvement in the efficiency of working capital utilization to generate revenue over the observed six-year period, despite intermittent volatility in liquidity levels.

Net Sales Growth
A consistent upward trajectory in net sales is observed, rising from 30,117 million in 2021 to 36,364 million by 2026. This steady expansion indicates a sustained increase in top-line revenue generation across the timeframe.
Working Capital Fluctuations
Working capital levels exhibit significant volatility. Following a peak of 14,039 million in 2021, a sharp decline occurred in 2022 to 10,665 million. Subsequent years showed irregular movements, with a moderate increase in 2023 and a gradual decline through 2025, before rising again to 13,129 million in 2026.
Working Capital Turnover Efficiency
The working capital turnover ratio demonstrates a general increase in operational efficiency. Starting at 2.15 in 2021, the ratio peaked at 3.07 in 2025. The fluctuations in this ratio are primarily driven by the volatility in working capital rather than sales, as the numerator remained relatively stable in its growth pattern. The slight decline to 2.77 in 2026 correlates with the increase in working capital during that final period.
Operational Insight
The divergence between the steadily increasing net sales and the fluctuating working capital suggests an overall improvement in the ability to support higher sales volumes without a proportional increase in net current assets. The peak efficiency reached in 2025 indicates an optimal alignment of short-term resources relative to revenue generation.

AI Ask an analyst for more


Average Inventory Processing Period

Medtronic PLC, average inventory processing period calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data
Inventory turnover 2.14 2.12 2.15 2.03 2.20 2.43
Short-term Activity Ratio (no. days)
Average inventory processing period1 171 172 170 180 166 150
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 123 121 133 118 102
Intuitive Surgical Inc. 196 200 186 161 122
Average Inventory Processing Period, Sector
Health Care Equipment & Services 10 11 12 12 11
Average Inventory Processing Period, Industry
Health Care 48 48 50 46 46

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 2.14 = 171

2 Click competitor name to see calculations.


The analysis of short-term operating activity reveals a period of decreasing inventory efficiency followed by a phase of stabilization. Between 2021 and 2023, there was a noticeable deceleration in inventory movement, which subsequently plateaued through 2026.

Inventory Turnover
A downward trajectory was observed from 2021 to 2023, with the turnover ratio declining from 2.43 to a low of 2.03. Following this decline, the ratio demonstrated stabilization starting in 2024, fluctuating within a narrow range between 2.12 and 2.15 over the subsequent three fiscal years.
Average Inventory Processing Period
The duration required to process inventory increased steadily from 150 days in 2021 to a peak of 180 days in 2023. This expansion indicates a lengthening of the operating cycle during that period. After 2023, the processing period contracted to 170 days and remained relatively constant, concluding the period at 171 days in 2026.

The inverse correlation between the turnover ratio and the processing period highlights a period of heightened inventory accumulation or slower sales velocity peaking in 2023. The subsequent consistency in these metrics suggests that inventory management strategies reached a new equilibrium, maintaining a stable processing cycle of approximately 171 days.

AI Ask an analyst for more


Average Receivable Collection Period

Medtronic PLC, average receivable collection period calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data
Receivables turnover 5.47 5.15 5.28 5.21 5.71 5.51
Short-term Activity Ratio (no. days)
Average receivable collection period1 67 71 69 70 64 66
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 65 60 60 52 55
Elevance Health Inc. 22 20 20 19 18
Intuitive Surgical Inc. 55 54 58 55 50
UnitedHealth Group Inc. 19 21 21 20 18
Average Receivable Collection Period, Sector
Health Care Equipment & Services 26 26 27 25 25
Average Receivable Collection Period, Industry
Health Care 48 46 48 44 46

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 5.47 = 67

2 Click competitor name to see calculations.


The analysis of short-term operating activity reveals a consistent pattern in the management of accounts receivable over the observed six-year period. Both the receivables turnover and the average collection period exhibit moderate fluctuations, indicating a stable credit policy and predictable cash flow recovery from customers.

Receivables Turnover
The turnover ratio demonstrates a non-linear trend, peaking at 5.71 in April 2022 before experiencing a gradual decline to a low of 5.15 by April 2025. A recovery is observed in April 2026, with the ratio increasing to 5.47. These movements suggest periodic variations in the velocity of receivable conversions, although the values remain within a relatively narrow range, suggesting consistent operational efficiency.
Average Receivable Collection Period
The collection period fluctuates in inverse correlation with the turnover ratio, ranging from a minimum of 64 days in April 2022 to a maximum of 71 days in April 2025. A notable expansion of the collection cycle occurred between 2022 and 2023, when the period increased from 64 to 70 days. The most recent data from April 2026 indicates a reduction to 67 days, signaling a return toward more efficient collection timelines.

AI Ask an analyst for more


Operating Cycle

Medtronic PLC, operating cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data
Average inventory processing period 171 172 170 180 166 150
Average receivable collection period 67 71 69 70 64 66
Short-term Activity Ratio
Operating cycle1 238 243 239 250 230 216
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 188 181 193 170 157
Intuitive Surgical Inc. 251 254 244 216 172
Operating Cycle, Sector
Health Care Equipment & Services 36 37 39 37 36
Operating Cycle, Industry
Health Care 96 94 98 90 92

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 171 + 67 = 238

2 Click competitor name to see calculations.


The operating cycle has experienced an overall expansion over the analyzed period, increasing from 216 days in 2021 to 238 days by 2026. The most significant growth occurred between 2021 and 2023, where the cycle peaked at 250 days before entering a period of relative stabilization between 238 and 243 days.

Average Inventory Processing Period
A notable upward trend is observed in the inventory processing period, which rose from 150 days in 2021 to a peak of 180 days in 2023. Following this peak, the duration stabilized, fluctuating minimally between 170 and 172 days from 2024 through 2026. This indicates a structural increase in the time required to move inventory through the production and sales pipeline compared to the 2021 baseline.
Average Receivable Collection Period
The receivable collection period demonstrates consistent performance, remaining within a narrow range of 64 to 71 days throughout the entire period. The lack of significant volatility suggests that credit policies and collection efficiencies have remained stable, regardless of the changes observed in inventory management.
Operating Cycle Synthesis
The expansion of the total operating cycle is almost exclusively attributable to the increase in the average inventory processing period. Because the receivable collection period remained steady, the total time elapsed from the initial acquisition of inventory to the final collection of cash shifted upward in alignment with the inventory holding trends.

AI Ask an analyst for more


Average Payables Payment Period

Medtronic PLC, average payables payment period calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data
Payables turnover 4.81 4.75 4.65 4.03 4.46 4.98
Short-term Activity Ratio (no. days)
Average payables payment period1 76 77 78 91 82 73
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Abbott Laboratories 80 82 87 88 87
Elevance Health Inc. 42 45 47 49 48
Intuitive Surgical Inc. 27 26 29 26 25
UnitedHealth Group Inc. 46 47 49 50 48
Average Payables Payment Period, Sector
Health Care Equipment & Services 47 49 51 53 51
Average Payables Payment Period, Industry
Health Care 59 60 61 63 63

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 4.81 = 76

2 Click competitor name to see calculations.


The analysis of short-term operating activity reveals a fluctuating trend in payables management between 2021 and 2026, characterized by a period of decelerated payment cycles followed by a consistent correction toward higher efficiency.

Payables Turnover
A decline in the turnover ratio is observed from 4.98 in 2021 to a minimum of 4.03 in 2023. This downward movement indicates a reduction in the frequency with which supplier obligations were settled. Following the 2023 trough, a steady recovery trend emerged, with the ratio increasing to 4.65 in 2024, 4.75 in 2025, and reaching 4.81 by 2026.
Average Payables Payment Period
The payment period exhibited an inverse correlation with the turnover ratio, lengthening from 73 days in 2021 to a peak of 91 days in 2023. This extension suggests a temporary expansion of payment terms or a strategic effort to preserve liquidity by delaying cash outflows. From 2024 onward, the period contracted to 78 days and continued a gradual decline to 76 days by 2026, signaling a return to more accelerated settlement cycles.

Overall, the metrics indicate that the most significant extension of credit utilization occurred in 2023. Subsequent years demonstrate a systematic reduction in the time taken to settle payables, bringing the operating cycle close to the levels observed at the start of the analyzed period.

AI Ask an analyst for more


Cash Conversion Cycle

Medtronic PLC, cash conversion cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data
Average inventory processing period 171 172 170 180 166 150
Average receivable collection period 67 71 69 70 64 66
Average payables payment period 76 77 78 91 82 73
Short-term Activity Ratio
Cash conversion cycle1 162 166 161 159 148 143
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories 108 99 106 82 70
Intuitive Surgical Inc. 224 228 215 190 147
Cash Conversion Cycle, Sector
Health Care Equipment & Services -11 -12 -12 -16 -15
Cash Conversion Cycle, Industry
Health Care 37 34 37 27 29

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 171 + 6776 = 162

2 Click competitor name to see calculations.


The cash conversion cycle exhibits a general upward trajectory over the analyzed period, increasing from 143 days in April 2021 to a projected 162 days by April 2026. This expansion indicates a lengthening of the time required to convert resource inputs into cash flows from sales, suggesting a decrease in overall working capital efficiency.

Average Inventory Processing Period
A significant increase is observed between 2021 and 2023, where the period rose from 150 days to a peak of 180 days. Following this peak, the duration stabilized, fluctuating marginally between 170 and 172 days through 2026. This component represents the primary driver of the overall increase in the cash conversion cycle.
Average Receivable Collection Period
The collection period remains the most stable element of the operating cycle. Values fluctuate within a narrow range, starting at 66 days in 2021 and ending at 67 days in 2026, with a slight peak of 71 days in 2025. This suggests a consistent and controlled credit management policy.
Average Payables Payment Period
The payment period shows a distinct peak in 2023 at 91 days, up from 73 days in 2021. After 2023, there is a consistent contraction in the payment period, returning to 76 days by 2026. The reduction in the payables period after 2023 contributed to the further extension of the cash conversion cycle, as the company transitioned from extending vendor payments to more rapid settlements.

The interaction between these three components reveals that the increase in the cash conversion cycle was initially driven by rising inventory levels. While an extension of the payables payment period provided a partial offset until 2023, the subsequent normalization of payment terms, combined with sustained higher inventory processing times, resulted in a higher baseline for the cash conversion cycle in the latter years of the period.

AI Ask an analyst for more